Substance

ID:603

Names and Identifiers
Brand Name
Diethylaminoethyl P-AminobenzoateDuracillin A.S.GerovitalGerovital H-3JenacaineNorocaineNovocainePfizerpen-AsProcainScurocaineSpinocaineAnticortNissocaineAllocaineDuracaineProcaine HclProcaine, BaseChloroprocaine HclJenacainNeocaineNovocainPenicillin G ProcaineProcaine HydrochlorideVitamin H3NesacaineP-Aminobenzoyldiethylaminoethanol
IUPAC name
2-(diethylamino)ethyl 4-aminobenzoate
Synonyms
procaine HClProcaine
IUPAC Traditional name
procaine
Registration numbers
CAS Number
PubChem CID
PubChem SID
Properties
Physical Property
Solubility
9450 mg/L
Hydrophobicity(logP)
1.8
Molecule Details
Drug Groups
approved; investigational
Description
A local anesthetic of the ester type that has a slow onset and a short duration of action. It is mainly used for infiltration anesthesia, peripheral nerve block, and spinal block. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1016). [PubChem]
Indication
Used as a local anesthetic primarily in oral surgery
Pharmacology
Procaine is an anesthetic agent indicated for production of local or regional anesthesia, particularly for oral surgery. Procaine (like cocaine) has the advantage of constricting blood vessels which reduces bleeding, unlike other local anesthetics like lidocaine. Procaine is an ester anesthetic. It is metabolized in the plasma by the enzyme pseudocholinesterase through hydrolysis into para-aminobenzoic acid (PABA), which is then excreted by the kidneys into the urine.
Affected Organisms
Humans and other mammals
Biotransformation
Hydrolysis by plasma esterases to PABA
Half Life
7.7 minutes
Elimination
With normal kidney function, the drug is excreted rapidly by tubular excretion.
References
• Gentry CL, Lukas RJ: Local anesthetics noncompetitively inhibit function of four distinct nicotinic acetylcholine receptor subtypes. J Pharmacol Exp Ther. 2001 Dec;299(3):1038-48. [Pubmed]
External Links
Molecular Spectra
No Data Available
Click here to submit data
References
• Gentry CL, Lukas RJ: Local anesthetics noncompetitively inhibit function of four distinct nicotinic acetylcholine receptor subtypes. J Pharmacol Exp Ther. 2001 Dec;299(3):1038-48. Pubmed